Journal article

The association between dietary patterns, diabetes and depression

Joanna F Dipnall, Julie A Pasco, Denny Meyer, Michael Berk, Lana J Williams, Seetal Dodd, Felice N Jacka

Journal of Affective Disorders | ELSEVIER | Published : 2015


BACKGROUND: Type 2 diabetes and depression are commonly comorbid high-prevalence chronic disorders. Diet is a key diabetes risk factor and recent research has highlighted the relevance of diet as a possible risk for factor common mental disorders. This study aimed to investigate the interrelationship among dietary patterns, diabetes and depression. METHODS: Data were integrated from the National Health and Nutrition Examination Study (2009-2010) for adults aged 18+ (n=4588, Mean age=43yr). Depressive symptoms were measured by the Patient Health Questionnaire-9 and diabetes status determined via self-report, usage of diabetic medication and/or fasting glucose levels ≥126mg/dL and a glycated h..

View full abstract


Awarded by NHMRC

Funding Acknowledgements

JAP has received Grant/Research Support from the NHMRC, Perpetual, Amgen (Europe) GmBH, BUPA Foundation and Arthritis Australia and has received speaker fees from Amgen and Sanofi Aventis.MB has received Grant/Research Support from the NIH, Cooperative Research Centre, Simons Autism Foundation, Cancer Council of Victoria, Stanley Medical Research Foundation, MBF, NHMRC, Beyond Blue, Rotary Health, Geelong Medical Research Foundation, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Meat and Livestock Board, Organon, Novartis, Mayne Pharma, Servier and Woolworths, has been a speaker for Astra Zencca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck, Merck, Pfizer, Sanofi Synthelabo, Servier, Solvay and Wyeth, and served as a consultant to Astra Zeneca, Bioaclvantex, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck Merck and Servier. Drs. Copolov, MB and Bush are co-inventors of two provisional patents regarding the use of NAC and related compounds for psychiatric indications, which, while assigned to the Mental Health Research Institute, could lead to personal remuneration upon a commercialization event. MR is supported by a NHMRC Senior Principal Research Fellowship 1059660.LJW received grants front Eli Lilly, Pfizer, The University of Melbourne, Deakin University and NHMRC.SD has received Grants/Research Support from the Stanley Medical Research Institute, NHMRC, Beyond Blue, ARHRF, Simons Foundation, Geelong Medical Research Foundation, Fondation FondaMental, Eli Lilly, Glaxo SmithKline, Organon, Mayne Pharma and Servier, speaker's fees from Eli Lilly, advisory board fees from Eli Lilly and Novartis, and conference travel support from Servier.